| |||||||||
Former Names 129-Kras2tm1Tyj/J (Changed: 25-FEB-05 ) Type Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation N?+3 Donating Investigator Tyler Jacks, Massachusetts Institute of Technology Description
Homozygous mice die at about embryonic day 12-13. They have a hypocellular fetal liver which also displays extensive cell death. They also appear to have a defect in both the hematopoietic cells and their microenvironment.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Kras
008180 129S/Sv-Krastm4Tyj/J 008179 B6.129S4-Krastm4Tyj/J View Strains carrying other alleles of Kras (2 strains)
New 129 Nomenclature Bulletin
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Krastm1Tyj/Krastm1Tyj
involves: 129S2/SvPas
- lethality-prenatal/perinatal
- embryonic lethality during organogenesis (MGI Ref ID J:43433)
- on an inbred genetic background, homozygotes die between E12 and E14
- on a mixed 129S2/SvPas x C57BL/6 genetic background, homozygotes die between E12 and term; the number of viable embryos decreases with increased gestational age, with no mutants surviving past birth
- cardiovascular system phenotype
- pericardial edema (MGI Ref ID J:43433)
- at E12.5, mutant embryos display signs of edema, esp. in the pericardial space
- embryogenesis phenotype
- reduced embryo size (MGI Ref ID J:43433)
- homozygotes are morphologically normal up to E10.5, but become readily identifiable by their smaller size at E11.5
- growth/size phenotype
- fetal growth retardation (MGI Ref ID J:43433)
- on a mixed 129S2/SvPas x C57BL/6 genetic background, homozygotes show a more severe developmental delay, which is both coordinate and non-coordinate in nature
- at E18.5, some homozygotes of mixed background have developed limbs, skin, tail, and whiskers associated with E17.5-18.5, but eyes associated with E15.5
- beginning at E11.5, mutant embryos of an inbred genetic background exhibit a developmental delay ranging from 0.5 to 3 gestational days
- at E15.5 or older, a small % of homozygotes of mixed background display a non-coordinate development of internal organs
- reduced embryo size (MGI Ref ID J:43433)
- homozygotes are morphologically normal up to E10.5, but become readily identifiable by their smaller size at E11.5
- hematopoietic system phenotype
- abnormal hematopoiesis (MGI Ref ID J:43433)
- mutant embryos display a perturbed hematopoietic microenvironment in the fetal liver despite normal differentiation of hematopoietic progenitors in vitro or upon transplant into lethally irradiated recipients
- anemia (MGI Ref ID J:43433)
- at E12.5, mutant embryos are anemic
- homeostasis/metabolism phenotype
- pericardial edema (MGI Ref ID J:43433)
- at E12.5, mutant embryos display signs of edema, esp. in the pericardial space
- liver/biliary system phenotype
- pale liver (MGI Ref ID J:43433)
- at E12.5, mutant livers are much paler than wild-type livers
- small liver (MGI Ref ID J:43433)
- at E12.5, mutant livers are significantly smaller than wild-type livers
- liver hypoplasia (MGI Ref ID J:43433)
- at E12.5, mutant livers show a 2- to 8-fold reduction in total cell number relative to wild-type livers
- skin/coat/nails phenotype
- pallor (MGI Ref ID J:43433)
- at E12.5, homozygotes are pale with reduced superficial vasculature
- cellular phenotype
- increased apoptosis (MGI Ref ID J:43433)
- at E12.5, mutant fetal livers contain pyknotic nuclei in the distal portion of hepatic lobe
- in severely affected embryos, apoptotic cells are detected throughout the fetal liver
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Kras related
Krastm1Tyj relatedCancer Research
Increased Tumor Incidence (Adenomas: lung, induced)
Increased Tumor Incidence (Other Tissues/Organs: lung, induced)
Cancer Research
Genes Regulating Growth and Proliferation
Oncogenes
Developmental Biology Research
Internal/Organ Defects (liver)
Hematological Research
Hematopoietic Defects
Internal/Organ Research
Liver Defects
| Allele Symbol | Krastm1Tyj | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Tyler Jacks | ||
| Allele Type | Targeted (knock-out) | ||
| Common Name(s) | K-ras-; K-rasKO; K-rastm1; | ||
| Mutation Made By | Tyler Jacks, Massachusetts Institute of Technology | ||
| Strain of Origin | 129S2/SvPas | ||
| ES Cell Line Name | D3 | ||
| ES Cell Line Strain | 129S2/SvPas | ||
| Gene Symbol and Name | Kras, v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | ||
| Chromosome | 6 | ||
| Gene Common Name(s) | AI929937; C-K-RAS; K-RAS2A; K-RAS2B; K-RAS4A; K-RAS4B; K-ras; KI-RAS; KRAS1; KRAS2; Kirsten rat sarcoma oncogene 2, expressed; Kras-2; Kras2; NS3; RASK2; c-Ki-ras; expressed sequence AI929937; p21; | ||
| Molecular Note | Exon 1 was replaced by a neomycin cassette. [MGI Ref ID J:43433] | ||
Genotyping Protocols
Krastm1Tyj, STD PCR, vers. 1
Helpful Links
Optimizing PCR Protocols
Johnson L; Greenbaum D; Cichowski K; Mercer K; Murphy E; Schmitt E ; Bronson RT ; Umanoff H ; Edelmann W ; Kucherlapati R ; Jacks T. 1997. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 11(19):2468-81. [PubMed: 9334313] [MGI Ref ID J:43433]
Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE. 2001. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice. Oncogene 20(16):2044-9. [PubMed: 11360188] [MGI Ref ID J:69250]
Krastm1Tyj relatedCosta RM; Federov NB; Kogan JH; Murphy GG; Stern J; Ohno M; Kucherlapati R; Jacks T; Silva AJ. 2002. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 415(6871):526-30. [PubMed: 11793011] [MGI Ref ID J:74257]
Khalaf WF; White H; Wenning MJ; Orazi A; Kapur R; Ingram DA. 2005. K-Ras is essential for normal fetal liver erythropoiesis. Blood 105(9):3538-41. [PubMed: 15644420] [MGI Ref ID J:105055]
Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE. 2001. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice. Oncogene 20(16):2044-9. [PubMed: 11360188] [MGI Ref ID J:69250]
Ohno M; Frankland PW; Chen AP; Costa RM; Silva AJ. 2001. Inducible, pharmacogenetic approaches to the study of learning and memory. Nat Neurosci 4(12):1238-43. [PubMed: 11713472] [MGI Ref ID J:109368]
Patek CE; Arends MJ; Wallace WA; Luo F; Hagan S; Brownstein DG; Rose L; Devenney PS; Walker M; Plowman SJ; Berry RL; Kolch W; Sansom OJ; Harrison DJ; Hooper ML. 2008. Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis. Exp Cell Res 314(5):1105-14. [PubMed: 18062963] [MGI Ref ID J:133431]
Takahashi C; Contreras B; Bronson RT; Loda M; Ewen ME. 2004. Genetic Interaction between Rb and K-ras in the Control of Differentiation and Tumor Suppression. Mol Cell Biol 24(23):10406-15. [PubMed: 15542848] [MGI Ref ID J:94087]
Wang Y; Zhang Z; Lubet R; You M. 2005. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf. Oncogene 24(18):3042-9. [PubMed: 15846305] [MGI Ref ID J:98054]
Wang Y; Zhang Z; Lubet RA; You M. 2006. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice. Oncogene 25(8):1277-80. [PubMed: 16247444] [MGI Ref ID J:107333]
Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M. 2006. Prevention of lung cancer progression by bexarotene in mouse models. Oncogene 25(9):1320-9. [PubMed: 16247446] [MGI Ref ID J:107330]
Wikenheiser-Brokamp KA. 2006. Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci 63(7-8):767-80. [PubMed: 16465443] [MGI Ref ID J:108542]
Yan Y; Tan Q; Wang Y; Wang D; Jin M; Gordon T; Lubet RA; You M. 2007. Enhanced lung tumor development in tobacco smoke-exposed p53 transgenic and Kras2 heterozygous deficient mice. Inhal Toxicol 19 Suppl 1:183-7. [PubMed: 17886066] [MGI Ref ID J:138096]
Zhang J; Lodish HF. 2005. Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo. Proc Natl Acad Sci U S A 102(41):14605-10. [PubMed: 16203968] [MGI Ref ID J:102491]
Zhang Z; Wang Y; Vikis HG; Johnson L; Liu G; Li J; Anderson MW; Sills RC; Hong HL; Devereux TR; Jacks T; Guan KL; You M. 2001. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 29(1):25-33. [PubMed: 11528387] [MGI Ref ID J:71546]
Colony Maintenance
Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.